- Home
- CYRX
CYRX
CryoPort Inc.
as 05-20-2024 11:31am EST
$.
-
$.
-.%
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 692.1M | IPO Year: | N/A |
| Target Price: | $17.88 | AVG Volume (30 days): | 489.3K |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.00 - $23.50 | Next Earning Date: | 05-07-2024 |
| Revenue: | $225,030,000 | Revenue Growth: | -9.19% |
| Revenue Growth (this year): | 7.43% | Revenue Growth (next year): | 10.80% |
Share on Social Networks:
Stock Insider Trading Activity of CryoPort Inc. (CYRX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 25 '24 | Sell | $17.54 | 1,079 | $18,928.14 | 128,333 | SEC Form 4 |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 25 '24 | Sell | $17.54 | 1,367 | $23,980.32 | 77,444 | SEC Form 4 |
| Mandalam Ramkumar | CYRX | Director | Mar 15 '24 | Sell | $14.68 | 3,217 | $47,225.56 | 43,187 | SEC Form 4 |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 9 '24 | Sell | $16.35 | 1,418 | $23,187.70 | 74,373 | SEC Form 4 |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 9 '24 | Sell | $15.43 | 1,312 | $20,247.05 | 73,061 | SEC Form 4 |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '24 | Sell | $16.35 | 3,723 | $60,879.99 | 636,951 | SEC Form 4 |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '24 | Sell | $20.79 | 2,599 | $54,030.61 | 634,352 | SEC Form 4 |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '24 | Sell | $15.04 | 54,440 | $818,853.82 | 694,813 | SEC Form 4 |
| Hariri Robert J | CYRX | Director | Dec 14 '23 | Sell | $16.89 | 800 | $13,512.00 | 12,716 | SEC Form 4 |
| Hariri Robert J | CYRX | Director | Dec 11 '23 | Sell | $15.50 | 1,000 | $15,500.00 | 13,516 | SEC Form 4 |
Latest CryoPort Inc. News
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
GuruFocus.com
3 days ago
Insider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX)
Simply Wall St.
9 days ago
Cryoport, Inc.'s (NASDAQ:CYRX) CEO Compensation Looks Acceptable To Us And Here's Why
Simply Wall St.
11 days ago
Cryoport, Inc. (NASDAQ:CYRX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Insider Monkey
12 days ago
Cryoport, Inc. (NASDAQ:CYRX) Q1 2024 Earnings Call Transcript
GuruFocus.com
12 days ago
CryoPort Inc (CYRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com
13 days ago
CryoPort Inc (CYRX) Q1 2024 Earnings: Revenue Declines Amid Challenges, Yet Maintains Full-Year ...
PR Newswire
13 days ago
Cryoport Reports First Quarter 2024 Financial Results
MT Newswires
17 days ago